Sun Pharma signs deal with ICGEB to develop novel dengue vaccine

The announcement comes even as the world's first dengue vaccine, manufactured by Sanofi Pasteur, the vaccine unit of the French pharmaceutical company Sanofi, awaits approval in India.IANS | Updated: October 19, 2016, 14:59 IST

New Delhi: Indian drug major Sun Pharmaceutical Industries on Wednesday said it has entered into an agreement with the International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop a novel dengue vaccine for India and global markets.

"Our new collaboration with ICGEB for developing an affordable dengue vaccine is part of our broader commitment for developing new and improved vaccines and drugs against flaviviruses that are of significant health importance to India and rest of the world," said Kirti Ganorkar, Executive Vice President and Head, Global Business Development, Sun Pharma.

The announcement comes even as the world's first dengue vaccine, manufactured by Sanofi Pasteur, the vaccine unit of the French pharmaceutical company Sanofi, awaits approval in India. Sanofi Pasteur's dengue vaccine has received approval in 11 countries so far.

Nonprofit research organisation ICGEB has conducted pre-clinical studies over the past seven years and developed the existing know-how and patents for the novel dengue vaccine candidate.

"Our pre-clinical data is very encouraging and this could be an ideal dengue vaccine candidate for all target populations," Dinakar Salunke, Director, ICGEB, said.

This is the second collaboration between Sun Pharma and ICGEB focusing on dengue.

The first one, announced in May 2016, was related to the development of a botanical drug for treatment of dengue. The current collaboration is focussed on developing a novel, safe and effective vaccine for the prevention of dengue.

This Website Uses Cookies

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you've provided to them or that they've collected from your use of their services. Give your consent to our cookies for: